Shopping Cart
- Remove All
Your shopping cart is currently empty
ARN22089 is an oral active CDC42 GTPase interaction inhibitor that blocks tumour growth in BRAF mutant mouse melanoma models and patient-derived xenografts (PDXs) in vivo.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $117 | In Stock | |
| 5 mg | $289 | In Stock | |
| 10 mg | $428 | In Stock | |
| 25 mg | $718 | In Stock | |
| 50 mg | $1,070 | In Stock | |
| 100 mg | $1,590 | In Stock | |
| 200 mg | $2,180 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $318 | In Stock |
| Description | ARN22089 is an oral active CDC42 GTPase interaction inhibitor that blocks tumour growth in BRAF mutant mouse melanoma models and patient-derived xenografts (PDXs) in vivo. |
| Synonyms | ARN 22089 |
| Molecular Weight | 373.49 |
| Formula | C23H27N5 |
| Cas No. | 2248691-29-2 |
| Smiles | N=1C(=CC(=NC1C2CCNCC2)C=3C=CC=CC3)NC4=CC=CC(=C4)N(C)C |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.